The CIMAvax-EGF is a therapeutic vaccine developed in Cuba, designed to block the action of the epidermal growth factor (EGF), a protein that plays a critical role in the growth and proliferation of cancer cells [160]. The gene discussed is EGF; the disease is cancer.